NCT00316849: Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
|
| Completed | 1 | 56 | US | pharmacological study, pharmacological studies, adjuvant therapy, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT, intensity-modulated radiation therapy, IMRT, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, temozolomide, SCH 52365, Temodal, Temodar, TMZ | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma | 11/10 | | | |
NCT01204450: Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma |
|
|
| Terminated | 1 | 7 | US | Temsirolimus, Torisel, Valproic Acid, VPA | UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific | 11/12 | 03/13 | | |
